Lower Limb Amputations From All SGLT2 Inhibitors, or Just Invokana?
A “Black-Box Warning” about the increased risk of lower limb amputations was added to the drug labels for Invokana and Invokamet in July 2017. Since that time there has been a mix of opinions expressed...
View ArticleCases Of Fournier Gangrene Associated With Diabetes Drugs Invokana,...
The FDA has identified 55 unique cases of Fournier gangrene associated with diabetes drugs in the Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors class between March 1, 2013 and January 31, 2019. Of...
View ArticleQuestions Raised About Whether Fournier’s Gangrene Is A Side Effect Of...
At the recent American Diabetes Association (ADA) Scientific Sessions there were reportedly questions raised about whether there is an increased risk of Fournier’s gangrene when using Farxiga as well...
View ArticleSGLT2 Inhibitors Invokana, Farxiga, Jardiance Linked to Retinal Vein Occlusion
Since being approved by the FDA as diabetes drugs years ago, Invokana, Farxiga, and Jardiance — as well as Invokamet, Xigduo, Glyxambi, Synjardy, Qtern, Steglatro, Steglujan, Segluromet, and other...
View ArticleDrug Injury Lawsuits: List of Some Cases Filed in First Half of 2021
A drug injury lawsuit is a personal injury case or a wrongful death case involving a serious drug side effect or a severe adverse drug reaction. Here are some of the prescription medications for which...
View Article